SHILPAMED — Shilpa Medicare Share News
0.000.00%
Last trade - 00:00- IN₹184.31bn
- IN₹189.99bn
- IN₹15.39bn
Brief: Shilpa Medicare Announces Successful Completion Of Early Clinical Development And Ongoing Phase 3 Clinical Trial Of Drug Sml-007
Brief: Shilpa Medicare Says Europe GMP Approval Of Shilpa Medicare Unit 4, Jadcherla, Telangana
India's Shilpa Medicare climbs to over two-year high
Brief: Shilpa Medicare Approved Floor Price For Issue At 477.33 Rupees Per Share
Brief: Elpro International Acquires Equity Shares Of Shilpa Medicare
Brief: Shilpa Medicare Says US FDA Inspected Bio-Analytical Laboratory, Unit 7
Brief: Shilpa Medicare Says Europe Approval For Varenicline Tablets, 0.5 Mg And 1mg
Brief: Shilpa Medicare To Issue Securities Via QIP
Brief: Shilpa Medicare Says Europe (EMA) Inspection Of Bio-Analytical Laboratory, Unit 7
Brief: Shilpa Medicare Says Arbitrator Directed Co To Pay To Celltrion, Inc Damages For Breach Of Contract
India's Shilpa Medicare rises on German drug marketing approval
India's Shilpa Medicare up after unit gets Australia approval
Brief: Shilpa Medicare Says Unit VI, Dabaspet, Bengaluru Got Approval From TGA, Australia
Brief: Shilpa Medicare To Sell 4% Stake In Sravathi Advance Process Technologies
India's Shilpa Medicare up on clearing Australian inspection
Brief: Shilpa Medicare's Unit IV, Jadcherla, Telangana Clears TGA, Australia GMP Inspection
India's Shilpa Medicare jumps on government nod for oral spray
Brief: Shilpa Medicare Says Received Approval For Manufacture And Sale Of Oral Mucositis Spray
Brief: Shilpa Medicare Says Shilpa Pharma Lifesciences, Unit Ii, Raichur, Karnataka Has Cleared Pmda Japan, GMP Inspection